Opaleye Management’s Astria Therapeutics ATXS Stock Holding History

Opaleye Management’s Portfolio ATXS Stock Details ATXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell
2023 Q2	$2.54M	Buy
2023 Q1	$4.1M	Buy
2022 Q4	$3.9M	Buy
2022 Q3	$1.21M	Buy
2021 Q1	–	Sell
2020 Q4	$402K	Buy